Search Results - "Schwartz, J I"

Refine Results
  1. 1

    Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet by Schwartz, J. I., Vandormael, K., Malice, M. P., Kalyani, R. N., Lasseter, K. C., Holmes, G. B., Gertz, B. J., Gottesdiener, K. M., Laurenzi, M., Redfern, K.‐J., Brune, K.

    Published in Clinical pharmacology and therapeutics (01-07-2002)
    “…Background This study compared directly the renal effects of two selective cyclooxygenase (COX)‐2 inhibitors (rofecoxib and celecoxib) with naproxen (dual…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans by Pentikainen, P J, Saraheimo, M, Schwartz, J I, Amin, R D, Schwartz, M S, Brunner-Ferber, F, Rogers, J D

    Published in Journal of clinical pharmacology (01-02-1992)
    “…Twelve healthy male volunteers received single market-image 40-mg oral doses of lovastatin and simvastatin (both lactone prodrugs), or pravastatin (a…”
    Get more information
    Journal Article
  7. 7

    Lack of Pharmacokinetic Interaction between Rofecoxib and Methotrexate in Rheumatoid Arthritis Patients by Schwartz, Jules I., Agrawal, Nancy G. B., Wong, Peggy H., Bachmann, Kenneth A., Porras, Arturo G., Miller, Jutta L., Ebel, David L., Sack, Marshall R., Holmes, Gregory B., Redfern, Jan S., Gertz, Barry J.

    Published in Journal of clinical pharmacology (01-10-2001)
    “…Rofecoxib is a highly selective and potent inhibitor of cyclooxgenase‐2 (COX‐2). Methotrexate is a disease‐modifying agent with a narrow therapeutic index…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Effect of Multiple Doses of Rifampin on the [14C N-methyl] Erythromycin Breath Test in Healthy Male Volunteers by Gharaibeh, Munir N., Gillen, Lisa P., Osborne, Barbara, Schwartz, Jules I., Waldman, Scott A.

    Published in Journal of clinical pharmacology (01-06-1998)
    “…The erythromycin breath test (EBT), which measures 14CO2 produced from [14C N‐methyl] erythromycin, is one of the most frequently employed measures to examine…”
    Get full text
    Journal Article
  10. 10

    Novel oral medication delivery system for famotidine by Schwartz, J I, Yeh, K C, Berger, M L, Tomasko, L, Hoover, M E, Ebel, D L, Stauffer, L A, Han, R, Bjornsson, T D

    Published in Journal of clinical pharmacology (01-04-1995)
    “…A famotidine wafer that rapidly disperses on the tongue without water is a novel alternative to other histamine2 (H2)-antagonist dosage forms. Benefits…”
    Get more information
    Journal Article
  11. 11

    Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patients by SCHWARTZ, J. I, JAUREGUI, L. E, BACHMANN, K. A, MARTIN, M. E, REITBERG, D. P

    Published in Antimicrobial Agents and Chemotherapy (01-05-1988)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  12. 12

    Plasma concentrations and effect on testosterone metabolism after single doses of MK-0434, a steroid 5 alpha-reductase inhibitor, in healthy subjects by VAN HECKEN, A, DEPRE, M, SCHWARTZ, J. I, TJANDRAMAGA, T. B, WINCHELL, G. A, DE LEPELEIRE, I, NG, J, DE SCHEPPER, P. J

    Published in European journal of clinical pharmacology (01-03-1994)
    “…A four-period, two-panel, single-rising-dose study (0.1-100 mg) was conducted in healthy males to investigate the pharmacodynamics, tolerability and…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Inhibition of Exercise-Induced Bronchoconstriction by MK-571, a Potent Leukotriene D4–Receptor Antagonist by Manning, Patrick J, Watson, Richard M, Margolskee, Dorothy J, Williams, Vanessa C, Schwartz, Jules I, O'Byrne, Paul M

    Published in The New England journal of medicine (20-12-1990)
    “…EXERCISE is a common stimulus of bronchoconstriction in subjects with asthma. 1 Exercise-induced bronchoconstriction may be caused by alterations in the…”
    Get full text
    Journal Article
  15. 15

    The suitability of carbamazepine as a single-sample probe of human mixed function oxidase activity by Bachmann, K A, Schwartz, J I, Jauregui, L

    Published in Xenobiotica (1989)
    “…1. Carbamazepine concentrations measured in plasma and plasma ultrafiltrates by fluorescence polarization immunoassay (f.p.i.a.) from 0 to 48 h post-dose were…”
    Get more information
    Journal Article
  16. 16

    Pharmacodynamics of MK-0963, a new 5 alpha-reductase inhibitor: effects on serum androgen concentrations by Schwartz, J I, Laskin, O L, Meeter, C A, Patterson, P M, Schneider, S H, Lasseter, K C, Seibold, J R

    Published in Clinical pharmacology and therapeutics (01-01-1994)
    “…The hormonal effects after a 10-day administration of a 4-azasteroid inhibitor of 5 alpha-reductase, MK-0963 (previously L-654,066), were evaluated in 35…”
    Get more information
    Journal Article
  17. 17

    Predicting the ciprofloxacin‐theophylline interaction from single plasma theophylline measurements by Bachmann, KA, Schwartz, JI, Jauregui, L

    Published in British journal of clinical pharmacology (01-08-1988)
    “…The effect of ciprofloxacin treatment on theophylline clearance was evaluated with a theophylline multiple dose, multiple sample protocol and with a single…”
    Get full text
    Journal Article
  18. 18
  19. 19

    The bioavailability and nonlinear pharmacokinetics of MK-679 in humans by Cheng, H, Schwartz, J I, Lin, C, Amin, R D, Seibold, J R, Lasseter, K C, Ebel, D L, Tocco, D J, Rogers, J D

    Published in Biopharmaceutics & drug disposition (01-07-1994)
    “…MK-679 (R(-)-3-((3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)(3- (dimethylamino)-3-oxo-propyl)thio)methyl)thio)propanoic acid) is a potent and specific…”
    Get more information
    Journal Article
  20. 20

    P-434: Effect of rofecoxib, celecoxib, and naproxen on blood pressure (BP) in elderly volunteers by Schwartz, J. I., Malice, M. P., Kalyani, R., Lasseter, K., Holmes, G. B., Gertz, B. J., Gottesdiener, K., Laurenzi, M., Brune, K.

    Published in American journal of hypertension (01-04-2001)
    “…Nonsteroidal anti-inflammatory drugs (NSAIDs) can affect sodium reabsorption by decreasing the synthesis of renal prostaglandins. This and other effects may…”
    Get full text
    Journal Article